S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 61 to 120 of 161

Issue Date	Title / Author(s) / Citation	File
2015-11	Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure Cho, Kyoung Min; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.30 No.6, pp.891-898	view file DOI
2015-12	MET amplification, protein expression, and mutations in pulmonary adenocarcinoma Park, Seongyeol; Koh, Jaemoon; Kim, Dong-Wan; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.90 No.3, pp.381-387	DOI
2015-12	Mechanisms of Acquired Resistance to AZD9291 A Mutation-Selective, Irreversible EGFR Inhibitor Kim, Tae Min; Song, Ahnah; Kim, Dong-Wan; Kim, Soyeon; Ahn, Yong-Oon; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.12, pp.1736-1744	DOI
2015-12	A Possible Association Between Thyroid Cancer and Breast Cancer An, Jee Hyun; Hwangbo, Yul; Ahn, Hwa Young; Keam, Bhumsuk; Lee, Kyu Eun; Han, Wonshik; Park, Do Joon; Park, In Ae; Noh, Dong-Young; Youn, Yeo-Kyu; Cho, Bo Youn; Im, Seock-Ah; Park, Young Joo Thyroid, Vol.25 No.12, pp.1330-1338	DOI
2016-01	Gefitinib-induced interstitial lung disease in korean lung cancer patients Beom, Seung-Hoon; Kim, Dong-Wan; Sim, Sung Hoon; Keam, Bhumsuk; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog Cancer Research and Treatment, Vol.48 No.1, pp.88-97	view file DOI
2016-01	Reduced dose intensities of doxorubicin in elderly patients with DLBCL in rituximab era Ha, Hyerim; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog Cancer Research and Treatment, Vol.48 No.1, pp.304-311	view file DOI
2016-02	Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study Kim, Ryul; Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Kim, Jin Ho; Paeng, Jin Chul; Kwon, Seong Keun; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog BMC Cancer, Vol.16, p. 116	view file DOI
2016-02	Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis Cha, Soojin; Lee, Jeongeun; Shin, Jong-Yeon; Kim, Ji-Yeon; Sim, Sung Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Se-Hoon; Kim, Jong-Il BMC Cancer, Vol.16, p. 170	view file DOI
2016-02	Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience Ock, Chan-Young; Keam, Bhumsuk; Lim, Yoojoo; Kim, Tae Min; Lee, Se-Hoon; Kwon, Seong Keun; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Head and Neck, Vol.38 No.2, pp.277-284	DOI
2016-03	Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer Park, Sehhoon; Park, Seongyeol; Lee, Se-Hoon; Suh, Beomseok; Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog Cancer Biomarkers, Vol.16 No.3, pp.425-433	DOI
2016-03	Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors Sim, Sung Hoon; Beom, Seung-Hoon; Ahn, Yong-Oon; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thoracic Cancer, Vol.7 No.2, pp.161-166	view file DOI
2016-03	EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1 alpha and STAT3 Koh, Jaemoon; Jang, Ji-Young; Keam, Bhumsuk; Kim, Sehui; Kim, Moon-Young; Go, Heounjeong; Kim, Tae Min; Kim, Dong-Wan; Kim, Chul-Woo; Jeon, Yoon Kyung; Chung, Doo Hyun OncoImmunology, Vol.5 No.3, p. e1108514	DOI
2016-03	PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma Ock, Chan-Young; Kim, Sehui; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Jin-Ho; Jeon, Yoon Kyung; Lee, Ju-Seog; Kwon, Seong Keun; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Oncotarget, Vol.7 No.13, pp.15901-15914	view file DOI
2016-03	Phase I study of random healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumors Yang, Yaewon; Lim, Okjae; Kim, Tae Min; Ahn, Yong-Oon; Choi, Hana; Chung, Hyejin; Min, Bokyung; Her, Jung Hyun; Cho, Sung Yoo; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Hwang, Yu Kyeong; Heo, Dae Seog Cancer immunology research, Vol.4 No.3, pp.215-224	DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-04	Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma Ock, Chan-Young; Son, Bongjun; Keam, Bhumsuk; Lee, Seung-Youn; Moon, Jaewoo; Kwak, Hwanjong; Kim, Sehui; Kim, Tae Min; Jeon, Yoon Kyung; Kwon, Seong Keun; Hah, J. Hun; Lee, Se-Hoon; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.142 No.4, pp.873-883	DOI
2016-04	VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma Park, Seongyeol; Nam, Soo Jeong; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Noon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Sung, Myung-Whun; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.2, pp.518-526	view file DOI
2016-05	Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: A role in organ preservation Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Han, Doo Hee; Won, Tae-Bin; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Kim, Dong-Young; Rhee, Chae-Seo; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.31 No.3, pp.570-578	view file DOI
2016-05	Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration Ock, Chan-Young; Keam, Bhumsuk; Kim, Sehui; Lee, Ju-Seog; Kim, Miso; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Chung, Doo Hyun; Heo, Dae Seog Clinical Cancer Research, Vol.22 No.9, pp.2261-2270	DOI
2016-07	Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations Suh, Koung Jin; Keam, Bhumsuk; Kim, Miso; Park, Young Sik; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.17 No.4, pp.245-252.e1	DOI
2016-07	Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer Han, Jae Joon; Kim, Dong-Wan; Koh, Jaemoon; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Clinical Lung Cancer, Vol.17 No.4, pp.263-270	DOI
2016-07	The effect of induction chemotherapy using docetaxel, cisplatin, and fluorouracil on survival in locally advanced head and neck squamous cell carcinoma: A meta-analysis Kim, Ryul; Hahn, Seokyung; Shin, Junghoon; Ock, Chan-Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Cancer Research and Treatment, Vol.48 No.3, pp.907-916	view file DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-10	Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma Kim, Ryul; Keam, Bhumsuk; Kwon, Dohee; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Hak Jae; Jeon, Yoon Kyung; Park, In Kyu; Kang, Chang Hyun; Kim, Dong-Wan; Kim, Young Tae; Heo, Dae Seog World Journal of Gastroenterology, Vol.22 No.37, pp.8389-8397	view file DOI
2016-11	Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations Park, Sehhoon; Park, Seongyeol; Lee, Se-Hoon; Suh, Beomseok; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.31 No.6, pp.1140-1149	view file DOI
2017-03	Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer Shin, Junghoon; Keam, Bhumsuk; Kim, Miso; Park, Young Sik; Kim, Tae Min; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog Journal of Thoracic Oncology, Vol.12 No.3, pp.520-528	DOI
2017-03	Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles Keam, Bhumsuk; Kim, Min-Kyung; Choi, Yunhee; Choi, Su-Jin; Choe, Pyoeng Gyun; Lee, Kyung-Hun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Nam-Joong; Heo, Dae Seog; Park, Wan Beom; Oh, Myoung-don Cancer, Vol.123 No.5, pp.841-848	DOI
2017-04	MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics Kwon, Dohee; Koh, Jaemoon; Kim, Sehui; Go, Heounjeong; Kim, Young A; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Jeon, Yoon Kyung; Chung, Doo Hyun Lung Cancer, Vol.106, pp.131-137	DOI
2017-04	Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer Kim, Miso; Keam, Bhumsuk; Kim, Tae-Min; Kim, Hoon-Gu; Kim, Jin-Soo; Lee, Sung Sook; Shin, Seong Hoon; Kim, Min Kyoung; Park, Keon Uk; Kim, Dong-Wan; Yun, Hwan Jung; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.49 No.2, pp.416-422	view file DOI
2017-04	Reply to Influenza Vaccination in Patients With Cancer Keam, Bhumsuk; Kim, Min-Kyung; Park, Wan Beom Cancer, Vol.123 No.7, pp.1273-1273	DOI
2017-05	Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy Lim, Yu Jin; Chang, Ji Hyun; Kim, Hak-Jae; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Paeng, Jin Chul; Kang, Keon Wook; Chung, June-Key; Jeon, Yoon Kyung; Chung, Doo Hyun; Wu, Hong-Gyun Clinical Lung Cancer, Vol.18 No.3, pp.e169-e178	DOI
2017-05	Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type Sim, Sung Hoon; Kim, Soyeon; Kim, Tae Min; Jeon, Yoon Kyung; Nam, Soo Jeong; Ahn, Yong-Oon; Keam, Bhumsuk; Park, Hyun Ho; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog American Journal of Pathology, Vol.187 No.5, pp.980-986	DOI
2017-05	KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer Park, Sehhoon; Kim, Ji-Yeon; Lee, Se-Hoon; Suh, Beomseok; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.32 No.3, pp.514-522	view file DOI
2017-06	Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma Ock, Chan-Young; Kim, Sehui; Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Chung, Eun-Jae; Kim, Jin-Ho; Kim, Tae Min; Kwon, Seong Keun; Jeon, Yoon Kyung; Jung, Kyeong Chun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung Whun; Heo, Dae Seog Oncotarget, Vol.8 No.58, pp.97920-97927	view file DOI
2017-09	Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas Lee, June-Koo; Lee, Junehawk; Kim, Sehui; Kim, Soyeon; Youk, Jeonghwan; Park, Seongyeol; An, Yohan; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog; Kim, Young Tae; Kim, Jin-Soo; Kim, Se Hyun; Lee, Jong Seok; Lee, Se-Hoon; Park, Keunchil; Ku, Ja-Lok; Jeon, Yoon Kyung; Chung, Doo Hyun; Park, Peter J.; Kim, Joon; Kim, Tae Min; Ju, Young Seok Journal of Clinical Oncology, Vol.35 No.26, pp.3065-3074	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-11	The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors Kim, Hyungjin; Park, Chang Min; Keam, Bhumsuk; Park, Sang Joon; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Goo, Jin Mo PLoS ONE, Vol.12 No.11, p. e0187500	view file DOI
2018-01	Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor Park, Sehhoon; Ha, Seunggyun; Lee, Se-Hoon; Paeng, Jin Chul; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog PLoS ONE, Vol.13 No.1, p. e0189766	view file DOI
2018-02	Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection Kim, Hyungjin; Chae, Kum Ju; Yoon, Soon Ho; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Goo, Jin Mo; Park, Chang Min European Radiology, Vol.28 No.2, pp.861-868	DOI
2018-03	Efficacy of pemetrexed-based chemotherapy in comparison to non-pemetrexed-based chemotherapy in advanced, ALK plus non-small cell lung cancer Jo, Jaemin; Kim, Se Hyun; Kim, Yu Jung; Lee, Juhyun; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Chung, Jin-Haeng; Jeon, Yoon Kyung; Lee, Jong Seok Yonsei Medical Journal, Vol.59 No.2, pp.202-210	view file DOI
2018-03	Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody Suh, Koung Jin; Kim, Se Hyun; Kim, Yu Jung; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Cancer Immunology, Immunotherapy, Vol.67 No.3, pp.459-470	DOI
2018-03	Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D.; Bang, Yung-Jue Cancer Science, Vol.109 No.3, pp.771-776	DOI
2018-06	Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Thoracic Cancer, Vol.9 No.6, pp.736-744	view file DOI
2018-07	The effect of hospice consultation on aggressive treatment of lung cancer Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Cancer Research and Treatment, Vol.50 No.3, pp.720-728	view file DOI
2018-08	Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Se Hyun; Kim, Yu Jung; Kim, Tae Min; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Esmo Open, Vol.3 No.5, p. e000332	DOI
2019	Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma Kang, Seong-Ho; Keam, Bhumsuk; Ahn, Yong-Oon; Park, Ha-Ram; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog OncoImmunology, Vol.8 No.1, p. e1515057	DOI
2019-01	A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma Kim, Miso; Kim, Tae Min; Keam, Bhumsuk; Kim, Yu Jung; Paeng, Jin Chul; Moon, Kyung Chul; Kim, Dong-Wan; Heo, Dae Seog Oncologist, Vol.24 No.1, pp.20-29	DOI
2019-01	Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors Kim, Ryul; Keam, Bhumsuk; Kim, Sehui; Kim, Miso; Kim, Se Hyun; Kim, Jin Wook; Kim, Yu Jung; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong Seok; Heo, Dae Seog BMC Cancer, Vol.19 No.1, p. 19	view file DOI
2019-01	The risk of herpes zoster in patients with non-small cell lung cancer according to chemotherapy regimens: Tyrosine kinase inhibitors versus cytotoxic chemotherapy Choi, Ji Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Jo, Seong Jin Cancer Research and Treatment, Vol.51 No.1, pp.169-177	view file DOI
2019-01	Significance of 18F-FDG PET parameters according to histologic subtype in the treatment outcome of stage III non–small-cell lung cancer undergoing definitive concurrent chemoradiotherapy Kim, Eunji; Wu, Hong-Gyun; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Paeng, Jin Chul; Kim, Hak Jae; Chang, Ji Hyun Clinical Lung Cancer, Vol.20 No.1, pp.E9-E23	DOI
2019-02	Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases Chung, Eun-Jae; Jeong, Woo-Jin; Jung, Young Ho; Kwon, Seong Keun; Kwon, Tack-Kyun; Ahn, Soon-Hyun; Sung, Myung-Whun; Keam, Bhumsuk; Heo, Dae-Seog; Kim, Jin Ho; Wu, Hong-Gyun; Lee, Keun-Wook; Eom, Keun-Yong; Rho, Young-Soo Oral Oncology, Vol.89, pp.84-94	DOI
2019-03	Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer Mehnert, Janice M; Varga, Andrea; Brose, Marcia S.; Aggarwal, Rahul R; Lin, Chia-Chi; Prawira, Amy; de Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A.; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D; Keam, Bhumsuk BMC Cancer. 2019 Mar 04;19(1):196	view file DOI
2019-05	Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients Yoo, Shin Hye; Keam, Bhumsuk; Ock, Chan-Young; Kim, Sehui; Han, Buhm; Kim, Ji-Won; Lee, Keun-Wook; Jeon, Yoon Kyung; Jung, Kyeong Cheon; Chung, Eun-Jae; Kwon, Seong Keun; Ahn, Soon-Hyun; Sung, Myung-Whun; Heo, Dae Seog Scientific Reports, Vol.9 No.1, p. 7680	DOI
2019-06	NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors Park, Ha-Ram; Ahn, Yong-Oon; Kim, Tae Min; Kim, Soyeon; Kim, Seulki; Lee, Yu Soo; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog Cytotherapy, Vol.21 No.6, pp.603-611	DOI
2019-07	Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib Kim, Seulki; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Alm, Yong-Oon; Keam, Bhumsuk; Heo, Dae Seog Cancer Research and Treatment, Vol.51 No.3, pp.951-962	view file DOI
2019-07	Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP Cho, Kyoung Min; Keam, Bhumsuk; Ha, Hyerim; Kim, Miso; Jung, Jae-Woo; Song, Woo-Jung; Kim, Tae Min; Jeon, Yoon Kyung; Kang, Hye-Ryun; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.34 No.4, pp.885-893	view file DOI
2019-07	Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer Kim, Su-Jung; Kim, Soyeon; Kim, Dong-Wan; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Lee, Yusoo; Koh, Jaemoon; Jeon, Yoon Kyung; Heo, Dae Seog Cancer Research and Treatment, Vol.51 No.3, pp.1231-1240	view file DOI
2019-07	Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer Choi, Mihong; Keam, Bhumsuk; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Clinical Lung Cancer, Vol.20 No.4, pp.E442-E451	DOI
2019-08	Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study Jung, Minsun; Kim, Soyeon; Lee, June-Koo; Yoon, Sun Och; Park, Heae Surng; Hong, Soon Won; Park, Weon-Seo; Kim, Ji Eun; Kim, Joon; Keam, Bhumsuk; Kim, Hyun Jik; Kang, Hyoung Jin; Kim, Dong-Wan; Jung, Kyeong Cheon; Kim, Young Tae; Heo, Dae Seog; Kim, Tae Min; Jeon, Yoon Kyung Oncologist, Vol.24 No.8, pp.E740-E748	DOI
2019-09	First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis Kim, Ryul; Keam, Bhumsuk; Hahn, Seokyung; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Clinical Lung Cancer, Vol.20 No.5, pp.331-338.e4	DOI

1 2 3